Hem/Onc Clerkship

Welcome to the Elective Rotation in Hematology/Oncology for Third and Fourth Year Medical Students. We have recently updated the educational components of this rotation to give you a broader experience while allowing you to focus on your chosen area of hematology or oncology.

Requirements of the clerkship include mandatory attendance at the following conferences:

Department of Medicine Grand Rounds on Tuesday morning at 7:30 a.m. (usually in LR-D)

Hematology/Oncology Grand Rounds on Thursdays mornings at 7:45 a.m. (usually in T2500)

Fellow Case Conferences twice a month

Tumor Boards

Resident Teaching Sessions 

Reading materials will be made available online in the near future. Topics include:

BENIGN HEMATOLOGY:

1 - Overview of Anemia

Current Concepts in the Pathophysiology and Treatment of Aplastic Anemia

Algorithm for the Laboratory Investigation of Anemia in Adults

2 - Bleeding Disorders

Hemophilia A and B

von Willebrand Disease

3 - Sickle Cell Anemia

Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease

Update in the Treatment of Sickle Cell Anemia

Disorders of Hemoglobin Structures

Complications Associated with Sickle Cell Trait

4 - Thrombocytopenia

General Aspects of Thrombocytopenia, Platelet Transfusions and Thrombopoietic Growth Factors

5 - Thrombophilia

Thrombophilia

Natural History of Venous Thromboembolism

6 - Metabolic Disorders

Hereditary Hemochromatosis

Guidelines for Management of Pediatric and Adult Tumor Lysis Syndrome

How I Treat Waldenstrom Macroglobulinemia

ONCOLOGY OVERVIEW:

7 - Overview of Chemotherapy (Cytotoxic Drugs & Molecularly Targeted Therapeutics)

Apoptosis and Non-apoptotic Deaths in Cancer Development and Treatment Response

Epigenetics in Cancer

Tumor Angiogenesis

Circulating Tumor Cells

Stem Cells and Cancer

2000 Years of Chemotherapy of Tumors

Oncogenes and Cancer

8 - Oncologic Emergencies

A Systemic Approach to the Bleeding Patient

9 - Neutropenic Fever

Infectious Complications

10 - Management of Adverse Events (Pain Management, Control of nausea & vomiting)/Palliative Care

American Society of Clinical Oncology Guidelines for Antiemetics in Oncology

MALIGNANT HEMATOLOGY:

11 - Common Leukemias

Evolving Paradigms in the Therapy of Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adults

Management of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Treatment of Adult Acute Lymphoblastic Leukemia

Curative Strategies in Acute Promyelocyte Leukemia

From Pathogenesis to Treatment of Chronic Lymphocytic Leukemia

12 - Lymphomas

Adult Burkitt Lymphoma

How I Treat Patients with Diffuse Large B-cell Lymphoma

Clinical Features, Prognosis and Treatment of Follicular Lymphoma

13 - Multiple Myeloma

14 - Stem Cell Transplantation

Hematopoietic Stem-Cell Transplantation

SOLID TUMORS:

15 - Gastrointestinal Cancers

Colon Cancer

Systemic Treatment of Colorectal Cancer

Renal Cancer

Kinase Targets in Renal-Cell Carcinoma

Renal-Cell Carcinomas

Update on the Application of Interleukin-2 in the Treatment of Renal-Cell Carcinoma

Carcinoid

16 - Breast Cancer

17 - Lung Cancer

The Role of Irreversible EGFR Inhibitors in the Treatment of Non-Small Cell Lung Cancer

The Revised TNM Staging System for Lung Cancer

Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Management of Lung Cancer in Older Adults

18 - Head and Neck Cancer

Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer

Chemotherapy Options for Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

19 - Genitourinary Cancers

Prostate - Localized Prostate Cancer

Testicular - Testicular Germ-Cell Cancer

Bladder - Bladder Cancer

20 - Gynecological Cancers

Ovarian Cancer

21 - Brain Tumors

Glioblastoma in Adults

22 - Miscellaneous References

Skin Cancer - Management of Cutaneous Melanoma

Sarcomas - Soft Tissue Sarcomas in Adults

Endocrine Malignant Neoplasms - Adrenocortical Carcinoma

 

Expectations of the Hematology/Oncology Rotation:

  • You will be responsible for two (2) patient write-ups during each week,

Week 1: 1 Inpatient; 1 Consult

Week 2: 1 Inpatient; 1 Clinic New Patient

  • Inpatient Service 
    • You are expected to round with interns and residents
    • Take the initiative to present your patients on attending rounds
    • Each week, you are required to give a 5-10 minute presentation on a topic relevant to one of your inpatients
    • Provide the attending a copy of a patient admission write-up that includes an H&P as well as an assessment and plan by problem
    • Remember to ask the attending to observe your skills while giving the patient a physical exam and your interaction with the patients
  • Consult Service
    • Participate in consultations on two afternoons each week
    • Remember to ask the attending to observe your skills while giving the patient a physical exam and your interaction with the patients
  • Rounds
    • Pick up patients with interns on inpatient service
    • Take initiative to present your patients succinctly by active problem during attending rounds
  • Outpatient Clinics
    • Outpatient Clinics in the afternoons are required for Thirs Year students on two weekdays. You are expected to attend different clinics on each day of your rotation to gain an appreciation of the various subspecialties within hematology/oncology
    • Case Conferences , organized by the fellows twice a month, provide a good opportunity to learn about various oncologic and hematologic diseases as well as their molecular pathogenesis and modern therapies

 

We look forward to providing a positive educational experience for each of you. Our goal is to enhance your learning experiences in the sub-specialty of hematology/oncology so that you can take away a good understanding of the problems the patients face as well as the approaches that are currently being used to manage them. We hope that you will also gain an appreciation for various psychosocial aspects, home care needs, the importance of communication with patients and families, goals of care in different settings, and appreciate the art of medicine in situations where only comfort measures are possible. We hope you also understand something about the limitations of the current diagnostic and therapeutic approaches and open questions for future research. Each of our faculty is involved in some research activities and there are numerous opportunities for additional learning experiences and research projects for interested students. We wish you well during your rotation and throughout your professional careers.

 

W. El-Deiry, M.D, Ph.D.

Division Chief, Hematology/Oncology